These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4375817)

  • 41. Management of keloids and hypertrophic scars.
    Tritto M; Kanat IO
    J Am Podiatr Med Assoc; 1991 Nov; 81(11):601-5. PubMed ID: 1784016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of keloids and hypertrophic scars.
    Juckett G; Hartman-Adams H
    Am Fam Physician; 2009 Aug; 80(3):253-60. PubMed ID: 19621835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Collagenase activity in cutaneous scars.
    Craig P
    Hand; 1973 Oct; 5(3):239-46. PubMed ID: 4355920
    [No Abstract]   [Full Text] [Related]  

  • 44. [Replication of pathological scar in nude mice].
    Jin PS; Cen Y; Liu XX; Chen JJ; Xu XW; Liu Y; Li JJ; Wang Y
    Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):126-9. PubMed ID: 17649888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of nude (athymic) mice for the study of hypertrophic scars and keloids: vascular continuity between mouse and implants.
    Kischer CW; Sheridan D; Pindur J
    Anat Rec; 1989 Nov; 225(3):189-96. PubMed ID: 2817436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and biochemical features of normal, defective, and pathologic scars.
    Nicoletis C; Bazin S; Lous ML
    Clin Plast Surg; 1977 Jul; 4(3):347-59. PubMed ID: 884926
    [No Abstract]   [Full Text] [Related]  

  • 47. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.
    Slemp AE; Kirschner RE
    Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the Role of Granzyme B in Exuberant Scar Pathogenesis: An Immunohistochemical Study.
    Bakry OA; Younes SF; Abdel Wahed M; El Farargy SM; Sharawy S
    Anal Quant Cytopathol Histpathol; 2015 Aug; 37(4):221-6. PubMed ID: 26410968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of scar contractures, hypertrophic scars, and keloids.
    Sherris DA; Larrabee WF; Murakami CS
    Otolaryngol Clin North Am; 1995 Oct; 28(5):1057-68. PubMed ID: 8559572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapeutic problems connected with keloid treatment--new treatment possibilities].
    Brudnik U; Podolec-Rubiś M; Wojas-Pelc A
    Przegl Lek; 2006; 63(9):803-6. PubMed ID: 17479875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the immunologic aspects of keloids and hypertrophic scars.
    Janssen de Limpens AM; Cormane RH
    Arch Dermatol Res; 1982; 274(3-4):259-66. PubMed ID: 6187300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevalence of hypertrophic and keloid scars according to the site of administration of intradermal BCG vaccine].
    Orges González I
    Bol Oficina Sanit Panam; 1980 Jun; 88(6):481-8. PubMed ID: 6448062
    [No Abstract]   [Full Text] [Related]  

  • 53. Histochemical study of healing wounds: alkaline and acid phosphatase.
    Itoiz ME; Mayo J; Cabrini RL; Carranza FA
    J Oral Surg; 1969 Aug; 27(8):641-4. PubMed ID: 5265207
    [No Abstract]   [Full Text] [Related]  

  • 54. The protruding scars: keloids and hypertrophic diagnosis and treatment with silicon-gel-sheeting.
    Tilkorn H; Ernst K; Osterhaus A; Schubert A; Schwipper V
    Polim Med; 1994; 24(1-2):31-44. PubMed ID: 7971533
    [No Abstract]   [Full Text] [Related]  

  • 55. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Activity detection and immunohistochemistry study on xanthine oxidase in pathological scars].
    Li WR; Cen Y; Li XH; Liao DY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):243-6. PubMed ID: 18630693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures.
    España A; Solano T; Quintanilla E
    Dermatol Surg; 2001 Jan; 27(1):23-7. PubMed ID: 11231236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histopathology of liver of rats infected by cysticercus of Taenia taeniaeformis. Part I. Changes in acid and alkaline phosphatases, beta-glucuronidase and esterase activities.
    Varute AT; Pillai MM
    Folia Histochem Cytochem (Krakow); 1974; 12(2):161-72. PubMed ID: 4442808
    [No Abstract]   [Full Text] [Related]  

  • 59. Alkaline and acid phosphatase activity in the initial phase of fracture healing.
    Raekallio J; Mäkinen PL
    Acta Pathol Microbiol Scand; 1969; 75(3):415-22. PubMed ID: 5801661
    [No Abstract]   [Full Text] [Related]  

  • 60. Differentiation of keloid and hypertrophic scar; correlation of the water proton relaxation times with the duration of the scar.
    Babu M; Bai RP; Suguna L; Ramachandran K; Ramakrishnan KM
    Physiol Chem Phys Med NMR; 1993; 25(2):113-20. PubMed ID: 8397424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.